Advertisement

Topics

Latest Biotechnology, Pharmaceutical and Healthcare News from ecancermedicalscience

00:18 EDT 16th October 2018 | BioPortfolio

Here are the most relevant search results for "ecancermedicalscience" found in our extensive news archives from over 250 global news sources.

More Information about ecancermedicalscience on BioPortfolio

In addition to our news stories we have dozens of PubMed Articles about ecancermedicalscience for you to read. Along with our medical data and news we also list ecancermedicalscience Clinical Trials, which are updated daily. BioPortfolio also has a large database of ecancermedicalscience Companies for you to search.

Showing News Articles 1–25 of 1,000+ from ecancermedicalscience

Friday 12th October 2018

Study holds promise for new paediatric brain tumour treatment

New research published in the journal Nature Communications from scientists at Huntsman Cancer Institute (HCI) at the University of Utah (U of U), in collaboration with the Stanford University School of Medicine, shows a specific protein regulates both...

New model mimics human tumours for accurate testing of cancer drugs

Walter and Eliza Hall Institute researchers have genetically engineered a new laboratory model that enables accurate testing of anti-cancer drugs by mimicking the complexity of human cancers. Using this advanced model, researchers will be able to...

New guideline for early-stage prostate cancer supports use of shortened courses of radiation therapy

Three prominent US medical societies today issued a new clinical guideline for physicians treating men with early-stage prostate cancer using external beam radiation therapy (EBRT). Adoption of the guideline could make treatment shorter and more...

'Build a wall' or 'tear down that wall'? Open access and libraries

By William Russell-Edu, librarian of the European Institute of Oncology, Milan, Italy I recently watched the documentary “Paywall: the Business of Scholarship”. If you haven’t seen it, I really suggest you do. As the makers of the film point out,...

Breast density info website launches European expansion

DenseBreast-info.org (DB-I) today announced the launch of its international expansion for European medical providers. DB-I is recognized as the most comprehensive, medically-sourced website for breast density information. The European expansion...

Thursday 11th October 2018

Increased survival in patients with metastatic NSCLC receiving treatment in academic centres

Patients with metastatic NSCLC receiving treatment at academic centres (ACs) have an increased 2-year survival compared to patients treated at community-based centres (CCs). An overall histology-dependent survival was also noted in patients with...

Genetics allows personalised disease predictions for chronic blood cancers

Scientists have developed a successful method to make truly personalised predictions of future disease outcomes for patients with certain types of chronic blood cancers. The study from the Wellcome Sanger Institute, the Wellcome-MRC Cambridge Stem Cell...

Researchers identify gene types driving racial disparities in myeloma

Researchers at Mayo Clinic have identified three specific gene types that account for a known two-to-three-fold increase in myeloma diagnoses among African-Americans. Researchers also demonstrated the ability to study race and racial admixture more...

Experts recommend that e-cigarettes should be used more actively to help smokers quit

"Ongoing nervousness" about the use of e-cigarettes in stop-smoking services can be a "significant" barrier to people finding support, research revealed during "Stoptober" shows. New research by the University of Exeter and University of Melbourne,...

Wednesday 10th October 2018

A tumour cell population responsible for resistance to therapy and tumour relapse

Resistance to therapy is a major problem in cancer patients as the cells that resist to therapy is at the root of tumour relapse and is associated with high morbidity and mortality. A better understanding of the mechanisms associated with resistance to...

Researchers uncover new role of TIP60 protein in controlling tumour formation

Scientists from the Cancer Science Institute of Singapore (CSI Singapore) at the National University of Singapore (NUS) have discovered a new molecular pathway that controls colorectal cancer development, and their exciting findings open new therapeutic...

New options for breast cancer drug development found in oestrogen receptors

Many breast cancer drugs block oestrogen receptors inside cancer cells. Blocking the receptors early in disease progression staves off metastasis. But most patients with advanced disease eventually develop drug resistance, leaving doctors desperate for...

Tuesday 9th October 2018

Targeted drugs for advanced cancer move from specialist units to community setting

Nearly 1 in 4 patients with advanced cancer, treated at Comprehensive Cancer Care Network (NCCN) centres in the US, are receiving innovative drugs matched to DNA mutations in their tumours. This achievement, to be reported at the ESMO 2018 Congress in...

Atrial fibrillation patients with cancer history less likely to see cardiologist, fill prescriptions

Atrial fibrillation (AFib) patients with a history of cancer are less likely to see a cardiologist or fill anticoagulant prescriptions compared with AFib patients who never had cancer, according to a study in the Journal of the American College of...

Monday 8th October 2018

Last Month in Oncology with Dr. Bishal Gyawali: September 2018

Long list of news in lung cancer Last month was an important month in oncology—especially for lung cancer. The World Conference in Lung Cancer (WCLC) 2018 gave us some important practice-changing results, also leading to four NEJM publications. The...

Researchers uncover a tumour cell population responsible for resistance to therapy and tumour relapse

Resistance to therapy is a major problem in cancer patients as the cells that resist to therapy is at the root of tumour relapse and is associated with high morbidity and mortality. A better understanding of the mechanisms associated with resistance to...

Neoadjuvant combination checkpoint blockade trial yields high response rates for patients with high-risk stage three melanoma

Combination checkpoint blockade before surgery (neoadjuvant therapy) produced a high response rate among patients with high-risk stage 3 melanoma, with nearly half having no sign of disease at surgery, but a high incidence of side effects caused the trial...

FDA approves cemiplimab-rwlc for metastatic or locally advanced cutaneous squamous cell carcinoma

On Sept. 28, 2018, the Food and Drug Administration approved cemiplimab-rwlc for patients with metastatic cutaneous squamous cell carcinoma (CSCC) or locally advanced CSCC who are not candidates for curative surgery or curative radiation. Approval was...

Tumour necrosis associate with atherosclerotic lipid accumulation

Inflammation is currently a well-documented component of atheroslcerosis pathogenesis, which plays a role at each stage of the disease development. Local activation of endothelial cells causing increase endothelial permeability, infiltration of intima...

Friday 5th October 2018

FDA approves carfilzomib once-weekly regimen for R/R multiple myeloma

The U.S. Food and Drug Administration (FDA) has approved the supplemental New Drug Application (sNDA) to expand the Prescribing Information for carfilzomib to include a once-weekly dosing option in combination with dexamethasone (once-weekly Kd70) for...

Thursday 4th October 2018

Compound derived from Chinese tree bark shows promise as treatment for pancreatic cancer

A new derivative of a compound found in the bark of a rare Chinese tree has powerful anticancer properties and a low toxicity profile, according to researchers at Roswell Park Comprehensive Cancer Centre. Results of their study of the effects of the...

Duvelisib has marked response, survival benefit in difficult-to-treat leukaemia & lymphoma

For some patients with difficult-to-treat leukemia and lymphoma, the investigational oral medicine duvelisib may significantly improve disease outcomes, according to phase III trial data published today in the journal Blood. The DUO trial studied the...

Novel T cell bispecific antibody for the targeted immune-mediated killing of HER2 breast cancer cells

It is not so long ago that immunotherapy against cancer was positioned as emerging or even promising but not as proven. Novel immunotherapeutics across different tumour types, either as monotherapy or in combination, are increasingly becoming one of the...

Colourful science - Success of melanoma immunotherapy stimulates clinical dermatology and pigment cell research

By Fabian V. Filipp, UC Merced New research published yesterday by council members of the International Federation of Pigment Cell Societies (IFPCS), the Pan-American Society for Pigment Cell Research (PASPCR), and the Melanoma Prevention Working Group...

Wednesday 3rd October 2018

Natural killer cells may open lifesaving cancer treatments to more patients

Immunotherapy is making headlines for saving the lives of hundreds of cancer patients including former President Jimmy Carter. But many of these therapies, only work for a small portion of people who have a specific molecule called PDL1 in their cancer...


Advertisement
Quick Search
Advertisement
Advertisement

 

News Quicklinks